Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.48 No.11

Vol.48 No.11 contents

The 49th Annual Meeting of the Japanese Society of Neurology

Migrainology learned from patients

Fumihiko Sakai, M.D.

CLINICA NEUROL, 48: 785|791, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Neuroscience in Japan: Its charm and challenge for future generations

Jun Kimura, M.D.

CLINICA NEUROL, 48: 792|797, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Molecular Mechanism of Migraine

Michael A. Moskowitz

CLINICA NEUROL, 48: 798|798, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Paraneoplastic Disorders of the Nervous System

Josep Dalmau, MD, PhD

CLINICA NEUROL, 48: 799|803, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Neuropathological perspective on single slide

Asao Hirano, M.D.

CLINICA NEUROL, 48: 804|808, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Reorienting health systems in the 21st century: the WHO Perspective

Linda L. Milan, M.D., M.P.H.

CLINICA NEUROL, 48: 809|814, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Toward a future Research in Neurology: molecular analysis of brain disorder

Katsuhiko Mikoshiba, M.D., Ph.D.

CLINICA NEUROL, 48: 815|820, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 821|822, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Molecular and genetic analysis of spinocerebellar ataxia type 10 (SCA10)

Tohru Matsuura, M.D.

CLINICA NEUROL, 48: 823|825, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Construction of regional system in support of homecare -What's required for clinical neurologist from patients-

Yoh Horikawa, M.D.

CLINICA NEUROL, 48: 826|830, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies

Satoshi Orimo, M.D.

CLINICA NEUROL, 48: 831|834, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Treatment of Parkinson's disease at present and in the future

Shigeki Kuzuhara, M.D., Ph.D.

CLINICA NEUROL, 48: 835|843, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Diagnosis and treatment of dystonia

Ryuji Kaji, M.D, Ph.D., Kenta Sato, M.D., Wataru Sako, M.D. and Satoshi Goto, M.D, Ph.D.

CLINICA NEUROL, 48: 844|847, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 848|848, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Progress in unravelling the etiology of multiple sclerosis?

Makoto Matsui, M.D., Ph.D.

CLINICA NEUROL, 48: 849|852, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Aphasia in practice -recent progress-

Mika Otsuki

CLINICA NEUROL, 48: 853|856, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Pathophysiology of migraine -migraine generator-

Junichi Hamada, M.D.

CLINICA NEUROL, 48: 857|860, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Prion disease -The present status and recent progress in Japan-

Hidehiro Mizusawa, M.D., Ph.D.

CLINICA NEUROL, 48: 861|865, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Diagnosis and management for acute ischemic stroke

Kazumi Kimura, M.D.

CLINICA NEUROL, 48: 866|870, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Limbic Encephalitis and Variants Related to Neuronal Cell Membrane Autoantigens

Josep Dalmau, MD, PhD

CLINICA NEUROL, 48: 871|874, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Dysphagia rehabilitation

Eiichi Saitoh, M.D., DM.Sc.

CLINICA NEUROL, 48: 875|879, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 880|883, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

How do we manage genetic testing for neurodegenerative diseases?

Kunihiro Yoshida, M.D.

CLINICA NEUROL, 48: 884|887, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 888|888, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

A new era has begun since the approval of thrombolytic therapy for acute ischemic stroke in Japan

Kazuo Minematsu, M.D., Ph.D.

CLINICA NEUROL, 48: 889|891, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Molecular epidemiology of cerebrovascular diseases; the Hisayama study and the Fukuoka Stroke Registry (FSR)

Takanari Kitazono, M.D.1), Michiaki Kubo, M.D.2), Jun Hata, M.D.3), Setsuro Ibayashi, M.D.4), Yutaka Kiyohara, M.D.3) and Mitsuo Iida, M.D.4)

CLINICA NEUROL, 48: 892|895, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-stem cell therapy

Koji Abe, M.D., Ph.D.

CLINICA NEUROL, 48: 896|898, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 899|899, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Development of new systems for monitoring the quality of stroke care in community

Yasuhiro Hasegawa

CLINICA NEUROL, 48: 900|901, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 902|902, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Recent progress and future direction of neurodegenerative disease research

Ryosuke Takahashi, M.D., Ph.D.

CLINICA NEUROL, 48: 903|905, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 906|906, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Targeting the structure and function relationships of the γ-secretase for the development of Alzheimer's disease

Taisuke Tomita, M.D.

CLINICA NEUROL, 48: 907|909, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse

Yasumasa Yoshiyama, M.D.

CLINICA NEUROL, 48: 910|912, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Pathomechanism of polyglutamine diseases and strategic design for their therapies

Nobuyuki Nukina, M.D.

CLINICA NEUROL, 48: 913|914, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 915|915, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Relationship between anti-NMDAR encephalitis and acute juvenile female non-herpetic encephalitis (AJFNHE)

Satoshi Kamei, M.D.

CLINICA NEUROL, 48: 916|919, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Clinical features and pathogenesis of anti-NMDA receptor encephalitis

Takahiro Iizuka, M.D.

CLINICA NEUROL, 48: 920|922, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Anti-NMDAR encephalopathy: treatment

Shigeaki Suzuki, M.D., Ph.D., Morinobu Seki, M.D. and Norihiro Suzuki, M.D., Ph.D.

CLINICA NEUROL, 48: 923|925, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Acute limbic encephalitis and NMDA type-glutamate receptor

Yukitoshi Takahashi, M.D.1)2), Etsuko Yamazaki, M.D.1), Shigeko Nishimura, M.D.1), Hisano Tsunogae, M.D.1), Kenji Niwa, M.D.3), Josep Dalmau, M.D.4), Katsumi Imai, M.D.1) and Tateki Fujiwara, M.D.1)

CLINICA NEUROL, 48: 926|929, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 930|930, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

To search for the pathogenesis of multiple sclerosis from the bedside

Jun-ichi Kira, M.D.

CLINICA NEUROL, 48: 931|933, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 934|934, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Approach to find new therapies for MS from clinical view

Masaaki Niino, M.D.

CLINICA NEUROL, 48: 935|936, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Therapeutic strategy against multiple sclerosis

Akio Suzumura, M.D.

CLINICA NEUROL, 48: 937|939, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 940|940, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Aquaporin-4

Kazutoshi Tani, Ph.D., Yoko Hiroaki, Ph.D. and Yoshinori Fujiyoshi, Ph.D.

CLINICA NEUROL, 48: 941|944, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Diffusion tensor imaging

Harushi Mori

CLINICA NEUROL, 48: 945|946, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Functional imaging in Binswanger's disease

Hidekazu Tomimoto, M.D.1)3), Masafumi Ihara, M.D.1), Ryosuke Takahashi, M.D.1) and Hidenao Fukuyama, M.D.2)

CLINICA NEUROL, 48: 947|950, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 951|951, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Introduction of neuroethics: Out of clinic, beyond academia in human brain research

Tamami Fukushi, Ph.D.1) and Osamu Sakura, Ph.D.1)2)

CLINICA NEUROL, 48: 952|954, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 955|957, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 958|960, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

What must we do for patients with ALS in the process of their decision making on TIPPV?

Hina Uetake

CLINICA NEUROL, 48: 961|962, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

From the Patient's View Point

Shoko Mukai

CLINICA NEUROL, 48: 963|964, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 965|965, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Amyotrophic lateral sclerosis with the SOD1 mutations

Masashi Aoki, M.D., Ph.D., Hitoshi Warita, M.D., Ph.D. and Yasuto Itoyama, M.D., Ph.D.

CLINICA NEUROL, 48: 966|969, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Exploration of pathogenesis-associated molecules and development of disease models for sporadic ALS

Fumiaki Tanaka, M.D.1), Masahiro Waza, M.D.1), Jun-ichi Niwa, M.D.2), Masahiko Yamamoto, M.D.3) and Gen Sobue, M.D.1)

CLINICA NEUROL, 48: 970|972, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

The end of life care for the patients with ALS in Japan

Mieko Ogino

CLINICA NEUROL, 48: 973|975, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 976|978, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 979|979, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 980|980, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Lewy body formation in Parkinson's disease: Neurodegeneration or neuroprotection?

Koichi Wakabayashi, M.D.

CLINICA NEUROL, 48: 981|983, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Cellular pathophysiology of Parkinson's disease

Atsushi Takeda, M.D., Naoto Sugeno, M.D., Takafumi Hasegawa, M.D., Michiko Kobayashi, M.D. and Akio Kikuchi, M.D.

CLINICA NEUROL, 48: 984|985, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Therapy of Parkinson's disease -up to date

Miho Murata

CLINICA NEUROL, 48: 986|988, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 989|989, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Frontotemporal dementia (FTD) and genetic mutations including progranulin gene

Tetsuaki Arai, M.D.1), Masato Hasegawa, Ph.D.2), Masugi Nishihara, Ph.D.3), Takashi Nonaka, Ph.D.2), Fuyuki Kametani, Ph.D.2), Mari Yoshida, M.D.4), Yoshio Hashizume, M.D.4), Thomas G Beach, M.D.5), Mitsuya Morita, M.D.6), Imaharu Nakano, M.D.6), Tatsuro Oda, M.D.7), Kuniaki Tsuchiya, M.D.8) and Haruhiko Akiyama, M.D.1)

CLINICA NEUROL, 48: 990|993, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

The significance of the TDP-43 deposition in FTLD-U and ALS

Masato Hasegawa, M.D.1), Tetsuaki Arai, M.D.2), Takashi Nonaka, M.D.1), Fuyuki Kametani, M.D.1), Mari Yoshida, M.D.3), Yoshio Hashizume, M.D.3), Thomas G Beach, M.D.4), Mitsuya Morita, M.D.5), Imaharu Nakano, M.D.5), Tatsuro Oda, M.D.6), Kuniaki Tsuchiya, M.D.7) and Haruhiko Akiyama, M.D.2)

CLINICA NEUROL, 48: 994|997, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Neuropathology of frontotemporal dementia

Shigeo Murayama, M.D., Ph.D.

CLINICA NEUROL, 48: 998|998, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

The early symptoms of frontotemporal lobar degeneration

Koichi Okamoto, M.D.

CLINICA NEUROL, 48: 999|1001, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Symptomatology of fronto-temporal dementia

Manabu Ikeda, M.D.

CLINICA NEUROL, 48: 1002|1004, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 1005|1005, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Pathogenesis and treatment of stroke-like episodes in MELAS

Takahiro Iizuka, M.D.

CLINICA NEUROL, 48: 1006|1009, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

L-arginine therapy on MELAS

Yasutoshi Koga

CLINICA NEUROL, 48: 1010|1012, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

A model mouse for mitochondrial DNA-based diseases

Kazuto Nakada, Ph.D., Akitsugu Sato, Ph.D. and Jun-Ichi Hayashi, Ph.D.

CLINICA NEUROL, 48: 1013|1015, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

New therapeutic strategy for mitochondrial diseases

Yu-ichi Goto

CLINICA NEUROL, 48: 1016|1017, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 48: 1018|1018, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Hereditary neuropathy: recent advance

Masanori Nakagawa, M.D.

CLINICA NEUROL, 48: 1019|1022, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Immune-mediated neuropathy

Susumu Kusunoki, M.D.

CLINICA NEUROL, 48: 1023|1025, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Metabolic and nutritional neuropathy

Naoki Hattori, M.D., Haruki Koike, M.D. and Gen Sobue, M.D.

CLINICA NEUROL, 48: 1026|1027, 2008

The 49th Annual Meeting of the Japanese Society of Neurology

Therapeutic strategy for peripheral nerve regeneration; molecular permeability control at the blood-nerve barrier

Takashi Kanda, M.D., Ph.D.

CLINICA NEUROL, 48: 1028|1030, 2008